These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia]. Chorfi M; Moussaoui D Encephale; 1985; 11(6):263-5. PubMed ID: 2869939 [TBL] [Abstract][Full Text] [Related]
23. Tardive dyskinesia and type II schizophrenia. Davis EJ; Borde M; Sharma LN Br J Psychiatry; 1992 Feb; 160():253-6. PubMed ID: 1347240 [TBL] [Abstract][Full Text] [Related]
24. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication. Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390 [TBL] [Abstract][Full Text] [Related]
29. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients. Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952 [TBL] [Abstract][Full Text] [Related]
30. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia. McEvoy J; Gandhi SK; Rizio AA; Maher S; Kosinski M; Bjorner JB; Carroll B Qual Life Res; 2019 Dec; 28(12):3303-3312. PubMed ID: 31435866 [TBL] [Abstract][Full Text] [Related]
31. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders. de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607 [TBL] [Abstract][Full Text] [Related]
33. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594 [TBL] [Abstract][Full Text] [Related]
34. Clinical correlates of distinct topographies of tardive dyskinesia in schizophrenia. Waddington JL; Youssef HA; Kinsella A Am J Psychiatry; 1993 Nov; 150(11):1757-8. PubMed ID: 8105709 [No Abstract] [Full Text] [Related]
35. The clinical correlates of neurological soft signs in chronic schizophrenia. King DJ; Wilson A; Cooper SJ; Waddington JL Br J Psychiatry; 1991 Jun; 158():770-5. PubMed ID: 1678661 [TBL] [Abstract][Full Text] [Related]
36. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients. Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765 [TBL] [Abstract][Full Text] [Related]
37. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Tan YL; Zhou DF; Zhang XY Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005 [TBL] [Abstract][Full Text] [Related]
38. Gender differences in tardive dyskinesia: a critical review of the literature. Yassa R; Jeste DV Schizophr Bull; 1992; 18(4):701-15. PubMed ID: 1359633 [TBL] [Abstract][Full Text] [Related]
39. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia]. Gałecki P; Pietras T; Florkowki A Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180 [TBL] [Abstract][Full Text] [Related]
40. Tardive dyskinesia--diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service. Lauterbach EC; Carter WG; Rathke KM; Thomas BH; Shillcutt SD; Vogel RL; Moore NC; Mimbs JW; Nelson WH Schizophr Bull; 2001; 27(4):601-13. PubMed ID: 11824487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]